Article: Asthma drug linked to rare condition. (Accolate, or zafirlukast, may cause Churg-Strauss syndrome)(Brief Article)

Article: AstraZeneca applies to US regulators to use asthma drug for smoker's cough
AP Worldstream;  April 30, 2008 ;     105 words ...AstraZeneca PLC said Wednesday it has applied to U.S. regulators for approval to use its Symbicort asthma drug to treat a condition commonly known as smoker's cough, which would strengthen its competition with rival drugmaker GlaxoSmithKline...

Article: FDA gives Avanir OK to test experimental, allergy and asthma drug. (Biotech).(Brief Article)
San Diego Business Journal;  March 24, 2003 ;     134 words ......Avanir Pharmaceuticals, which sells the and-herpes cream Abreva, said it won FDA permission to test an experimental allergy and asthma drug for its safety in healthy individuals. The compound known as AV 13358 aims to pre-empt the release of mediators involved in...

Article: Merck buying Schering-Plough in a $41.1B deal
AP Online;  March 9, 2009 ;     384 words ......billion in stock and cash in a deal that gives the maker of asthma drug Singulair more firepower to compete in a drug industry facing...pressures. The deal announced Monday would unite the maker of asthma drug Singulair with the maker of allergy medicine Nasonex. Merck...

Article: Acusphere Announces Results from First Human Clinical Study of Asthma Drug Candidate, AI-SR; AI-SR Demonstrates Sustained Release of Inhaled Asthma Drug.
Business Wire;  October 7, 2002 ;     629 words ......from its Phase I clinical study of its asthma drug candidate, AI-SR. This study, which was...microparticle formulation of a leading asthma drug. It is designed to slowly release the asthma drug locally in the lungs and thereby reduce...

Article: Volandri banned for 3 months for asthma drug abuse
AP Worldstream;  January 16, 2009 ;     113 words ......Italy will miss the Australian Open after being banned for three months by the International Tennis Federation for abusing an asthma drug. The Italian tennis federation announced the ITF's decision Friday, saying Volandri's use of salbutamol was deemed beyond...

Article: AaiPharma.(Eastern)(Brief Article)
Business North Carolina;  May 1, 2004 ;     85 words ......maker had hired Atlanta-based law firm King & Spalding to investigate sales irregularities involving its top products, the asthma drug Brethine and painkiller Darvocet. Frederick Sancilio replaced Philip Tabbiner. The company would delay its 2003 annual report...

Article: FTC requests more info from Merck, Schering-Plough
AP Online;  June 22, 2009 ;     94 words ......still expect the deal to close in the fourth quarter. The combined company would be the world's second-largest drugmaker by revenue, with products including the asthma drug Singulair, Nasonex for allergies, and the heart drugs Zetia and Vytorin.

Article: Cary.(Triangle)(Cornerstone BioPharma Holdings acquire Boston-based Critical Therapeutics )(Brief article)
Business North Carolina;  July 1, 2008 ;     59 words ......based Critical Therapeutics for about $63 million. The acquisition, expected to close by the end of the year, will add an asthma drug to Cornerstone's portfolio and make it a public company. Both companies employ about 80. No job cuts have been announced.

Article: Crying and inhaled Drugs.
Pediatrics for Parents;  September 1, 1999 ;     147 words ......doctors at The Royal Hospital for Sick Children, Edinburgh, Scotland, studied the amount of sodium cromoglycate, an inhaled asthma drug, inhaled by 15 infants. Seven of the infants were distressed, while the other eight weren't. The amount of the drug excreted...

Article: FDA adds black box to Xolair.(Warnings/Recalls)(Brief article)
Adverse Event Reporting News;  July 16, 2007 ;     143 words ...FDA finalized a strong new label warning patients and doctors about a potentially deadly allergic reaction from Genentech's asthma drug Xolair. The agency had proposed the so-called black box warning about anaphylaxis in February, but announced final wording...

Article: Volandri hits out at 3-month ban
AP Worldstream;  January 17, 2009 ;     252 words ......to miss the Australian Open. The Italian tennis federation announced the ITF's decision on Friday, saying Volandri's use of asthma drug salbutamol was deemed to have exceeded therapeutic needs. The ban began on Thursday and will end on April 14. Volandri failed...

Article: SEPRACOR HIRES CHIEF PATENT COUNSEL AND SENIOR DIRECTOR OF REGULATORY AFFAIRS.
Business Wire;  June 5, 1995 ;     418 words ......Sepracor Pharmaceuticals, said, With six drugs, most notably our asthma drug candidate R-albuterol, in human clinical trials, and more...Investigational New Drug (IND) and New Drug Applications (NDA) for a key asthma drug. Before joining Astra, Ms. Hall managed regulatory activities...

Article: Injury forces Kiefer out of Australian Open
AP Worldstream;  January 17, 2009 ;     153 words ......also replace Italy's Filippo Volandri, who was banned for three months by the International Tennis Federation for abusing an asthma drug. The Italian tennis federation announced the ITF's decision Friday, saying Volandri's use of salbutamol was deemed beyond...

Article: CAS finds Petacchi guilty of doping, stripped of Giro stage wins
AP Worldstream;  May 6, 2008 ;     265 words ......the end of August, applied retroactively from last November. The ruling relates to allegations Petacchi excessively used an asthma drug during last year's Giro. All competitive results obtained by Alessandro Petacchi during the 2007 Giro d'Italia shall be disqualified...